Home
About Us
Avalo Therapeutics is a clinical stage biotechnology company focused on the treatment of immune mediated inflammatory diseases.
Presentations
Recent News
Jun 18, 2025 7:00 am
Avalo Therapeutics Announces Appointment of Rita Jain, M.D. to Board of Directors
May 27, 2025 10:05 am
Avalo Therapeutics to Participate in Upcoming Investor Conferences
